Cell line name |
MPT-S1 |
Accession |
CVCL_B7GV |
Resource Identification Initiative |
To cite this cell line use: MPT-S1 (RRID:CVCL_B7GV) |
Comments |
Population: Chinese. Characteristics: Established from a nude mouse xenograft. Doubling time: 2-3 days (PubMed=35365682). Omics: Deep exome analysis. Derived from site: In situ; Breast; UBERON=UBERON_0000310. |
Sequence variations |
- Mutation; HGNC; HGNC:7133; KMT2D; Simple; c.6079_6082delAATT; Zygosity=Heterozygous (PubMed=35365682).
- Mutation; HGNC; HGNC:11957; MED12; Simple; p.Gly44Asp (c.131G>A); ClinVar=VCV000092220; Zygosity=Heterozygous (PubMed=35365682).
- Mutation; HGNC; HGNC:9884; RB1; Simple; c.1530_1531delAG; Zygosity=Heterozygous (PubMed=35365682).
- Mutation; HGNC; HGNC:9884; RB1; Simple; c.1588_1589delAA; Zygosity=Heterozygous (PubMed=35365682).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu252del (c.754_756delCTC); ClinVar=VCV000998484; Zygosity=Heterozygous (PubMed=35365682).
- Mutation; HGNC; HGNC:11998; TP53; Simple; c.750_754delinsA; Zygosity=Heterozygous (PubMed=35365682).
|
Disease |
Malignant breast phyllodes tumor (NCIt: C4504) Phyllodes tumor of the breast (ORDO: Orphanet_180261) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Female |
Age at sampling |
51Y |
Category |
Cancer cell line |
STR profile |
Source(s): PubMed=35365682
Markers:Amelogenin | X |
CSF1PO | 12 |
D1S1656 | 11,16 |
D2S441 | 12 |
D2S1338 | 23 |
D3S1358 | 15,16 |
D5S818 | 11 |
D7S820 | 12 |
D8S1179 | 11,13 |
D10S1248 | 13,14 |
D12S391 | 21 |
D13S317 | 9,12 |
D16S539 | 10,11 |
D18S51 | 18 |
D19S433 | 13.2 |
D21S11 | 29,30 |
D22S1045 | 14 |
DYS391 | 9 |
FGA | 19 |
Penta D | 9,14 |
Penta E | 11,19 |
TH01 | 9 |
TPOX | 8,9 |
vWA | 14,16 |
Run an STR similarity search on this cell line |
Publications | PubMed=35365682; DOI=10.1038/s41523-022-00413-1; PMCID=PMC8975864 Ng D.Y.X., Li Z.-M., Lee E., Kok J.S.T., Lee J.Y., Koh J., Ng C.C.-Y., Lim A.H., Liu W., Ng S.R., Lim K.S., Huang X.X., Hong J.H., Guan P.-Y., Sim Y.-R., Thike A.A., Md Nasir N.D., Li S., Tan P.H., Teh B.T., Chan J.Y.-S. Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor. NPJ Breast Cancer 8:44.1-44.7(2022) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_B7GV
|
Encyclopedic resources |
Wikidata; Q112930125
|
Entry history |
Entry creation | 23-Jun-2022 |
Last entry update | 19-Dec-2024 |
Version number | 6 |
---|